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There are 10 known mammalian septin genes, some of which produce multiple splice variants. The
current nomenclature for the genes and gene products is very confusing, with several different names
having been given to the same gene product and distinct names given to splice variants of the same
gene. Moreover, some names are based on those of yeast or Drosophila septins that are not the closest
homologues. Therefore, we suggest that the mammalian septin field adopt a common nomenclature
system, based on that adopted by the Mouse Genomic Nomenclature Committee and accepted by the
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Human Genome Organization Gene Nomenclature Committee. The human and mouse septin genes
will be named SEPT1–SEPT10 and Sept1–Sept10, respectively. Splice variants will be designated by an
underscore followed by a lowercase “v” and a number, e.g., SEPT4_v1.
The septins are a family of proteins that were first discov-
ered in the yeast Saccharomyces cerevisiae by analysis of mu-
tants defective in cytokinesis and bud morphogenesis. It is
now clear that they are widespread and probably ubiquitous
in the fungi and animals, although apparently not in plants.
Most if not all septins seem to bind and hydrolyze GTP and
to participate in filament formation in vitro and probably in
vivo. In addition to their widespread involvement in cyto-
kinesis, the septins seem also to be involved in vesicle traf-
ficking and other aspects of cell surface organization, and
they may have other functions as well. For various trivial
historical reasons, the current nomenclature for the mam-
malian septins is particularly chaotic and confusing. With
the field still young but attracting increasing interest, there
seems to be great value in rationalizing and simplifying the
septin nomenclature at this time.
In accordance with the Mouse Genomic Nomenclature
Committee nomenclature, the mouse genes will be named
Sept1–Sept10, and the corresponding protein products will
be SEPT1–SEPT10. Although these numbers do not corre-
spond to the genetic distances between the septins (Figure
1), they do provide an unambiguous and consistent naming
system. The Human Genome Organization Gene Nomencla-
ture Committee-approved symbols will be SEPT1–SEPT10
for the genes, and the corresponding gene products will be
SEPT1–SEPT10. Although there are still too few sequences
available to be certain, it seems likely that most or all septins
of other vertebrates will prove to have unambiguous ortho-
logues among the mammalian septins, in which case it
would be desirable to name them by using the same system.
For example, several fragments of septin genes from frog
and zebrafish are available in GenBank as expressed se-
quence tags (ESTs), and these encode peptides that are
highly related to particular mammalian septins. Therefore,
we suggest that where possible other vertebrate septins be
named using the same system as used for the mammalian
proteins. Usually, the species being described would be
obvious from the context, but it could also be indicated by
adding, as a prefix, an abbreviation of the Latin binomial for
the species (e.g., Xl for Xenopus laevis). For example, the frog
septin A (GenBank no. AF212298), which is 89% similar in
sequence to human SEPT2 but only 61% similar to the next
most closely related human septin, would now be named Xl
SEPT2, or just SEPT2. (However, the prefix would not be a
part of the official gene symbol.) At the same time, compar-
ison of the yeast, Caenorhabditis elegans and Drosophila sep-
tins to the mammalian septins (Adam, Peifer, and Pringle,
unpublished data) shows that the relationships are suffi-
ciently complicated that the mammalian nomenclature
scheme could not reasonably be applied to nonvertebrate
septins.
The proposed symbols are reconciled with the previously
used aliases for the mouse and human members of the
septin family in Table 1. This table also provides selected
GenBank accession numbers for the mouse and human sep-
tins, the N- and C-terminal sequences of the longest known
variants (so as to provide an unambiguous means of iden-
tification), and the human chromosome loci.
Note that some septins currently have a multitude of
distinct aliases (e.g., SEPT9 names include Sint1, Sep9, E-
septin, SLP-a, MSF, SepD1, and Ov/Br septin), and SEPT6
has been named both Septin 6 and Sept2, which engenders
considerable confusion in the literature and in database
searches. Additionally, some vertebrate septins (e.g., Cdc10
or Pnutl) have been named after Saccharomyces cerevisiae or
Drosophila septins that are not true orthologues (or even the
closest homologues). Finally, at least four septin genes pro-
duce multiple splice variants, and these have also sometimes
been given completely different names [e.g., SEPT4 splice
variants include hCDCrel-2a, hCDCrel-2b, Bradeion- and
-B, ARTS, MART, and Pnutl2(variants 1–4)]. To make the
genetic origin of these variants clear, we propose using the
system adopted by the Mouse and Human Genome Nomen-
clature Committees. In this system, splice variants are dis-
tinguished by an underscore followed by a lowercase “v”
and a number, as listed in Table 1, e.g., the mouse G-septin
 would be named SEPT3_v1. Finally, we propose that if new,
distinct septin genes are discovered, they and their products be
given a new number in the sequence (e.g., SEPT11).
Figure 1. Unrooted phylogenetic tree of human septins. This consen-
sus tree was generated using the Protpars program in the Phylip
package. Each of the 1000 bootstrapped replicate data sets generated
was analyzed 20 times, with the sequence input order randomized
each time. The branch values (percentage) refer to the frequency with
which a given branching pattern was produced. Strong support for any
particular branch shown in the figure is indicated by values90%, and
moderate-to-weak support is indicated by values between 60 and 90%.
Values 60% indicate no support for the given branching pattern.
Segment lengths do not correspond to relatedness.
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Table 1. Proposed nomenclature for mammalian septins
Approved mouse
septin
nomenclature
(Locus/
protein)
Approved human
septin
nomenclature
(Locus/
protein)
Mouse,
rat septin
aliasesa
Mouse, rat
GenBank
accession nos.
(selected)
Human septin
aliases
N-terminal
sequence
(human, longest
splice variant)
C-terminal
sequence
(human,
longest splice
variant)
Human
GenBank
accession nos
(selected)
Human
chromosome
locus
Sept1/SEPT1 SEPT1/SEPT1 Diff6, Septin1 M37030,
NM_017461
SEPT1 MDKEYVGF QGEQSDAL. NM_052838 16p11.1
Sept2/SEPT2 SEPT2/SEPT2 Nedd5, Septin2 NM_010891,
D49382
Nedd5, Pnutl3,
Diff6,
KIAA0158
MSKQQPTQ GGALGHHV. NM_004404,
AF038404
2q37.3
Sept3/
SEPT3_v1–3b
SEPT3/
SEPT3_v1–2c
G-septin(,,),
Septin3(A–C)
AF111179(),
AF111180(),
AF111181(),
NM_011889,
NM_019375
Sep3c MSELVPEP EESHDSNP. NM_019106 22q13.2
Sept4/
SEPT4_v1–6
SEPT4/
SEPT4_v1–6
H5, Sep4 NM_011129 H5,
Bradeion(,),
Pnutl2(variants
1–4),
hCDCrel-2(a–
b), ARTS,d
MARTd
MDRSLGWQ QKQMKENY. NM_004574,
NM_080415–7,
AF176379,
AB008753,
AB002110
17q23
Sept5/SEPT5 SEPT5/SEPT5 Cdcrel-1
Pnutl1e
NM_053931 Pnutl, hCDCrel-
1A, B
MSTGLRYK MKQQMQDQ.Y11593,
NM_002688
22q11.2
Sept6/SEPT6 SEPT6/SEPT6_v1–6 Septin6 NM_019942 SEPT2,
Septin6(I–VI),
KIAA0128
MAATDIAR KRDKEKKN. AF403058–62,
AB023622,
Xq24
Sept7/SEPT7 SEPT7/SEPT7 Septin7, Cdc10 NM_022616 hCdc10 MVAQQKNLE NKKKGKIF. AF142759,
NM_001788
7q36.1
Sept8/SEPT8 SEPT8/SEPT8 AA636820
(partial)
KIAA0202 MAATDLERFSf RKDKDKKN. D86957,
BAA13193.1
5q31
Sept9/
SEPT9_v1–5
SEPT9/
SEPT9_v1–5
Sint1, Sep9, E-
septin, SLP-a
NM_017380,
AJ250723
AF17q25 gene,
MSF(a–d),
SEPT9, SepD1,
Ov/Br septin,
Pnutl4,
KIAA0991
MKKSYSGGTR EKEPEAPEM. NM_006640,
AB023208,
AF189712,
AF123052
17q25.3
Sept10/SEPT10 SEPT10/SEPT10 AV254985
(partial)
SEPT10, Sep1-
like
MASSEVARHL QGQYISQSE. AF146760 8q11.23
Mouse locus symbols (italicized, first letter capitalized) are those approved by the Mouse Genomic Nomenclature Committee; human locus
symbols (italicized, all capital letters) have been approved by the Human Genome Organization Gene Nomenclature Committee. Where
possible, the Genbank accession numbers are those provided by the curated NCBI reference sequence project (http://www.ncbi.nlm.nih.gov:
80/locuslink/refseq.html). Selected accession numbers for various septin splice variants are also provided.
a Aliasas can still be used to search the mouse genome informatics site for septin genes of interest (http://www.informatics.jax.org).
b Several of the septin genes produce multiple splice variants. We propose a consistent naming convention for the splice variants, as adopted
by the Mouse and Human Genome Nomenclature Committees, in which an underscore and a “v” followed by a number is added as a suffix
for each variant.
c Human ESTs exist encoding a C-terminal sequence identical to the unique C-terminal sequence of rat G-septin . No human ESTs were
found that correspond to the unique N-terminus of G-septin , and it is not clear if this is a true splice variant.
d ARTS and MART are splice variants of the SEPT4 gene that lack the G4 motif (XKXD) found in typical septins. Uniquely, ARTS is localized
to mitochondria, is essential for TGF--mediated apoptosis, and translocates to the nucleus when apoptosis occurs. It is not known if ARTS
or MART binds guanine nucleotide. However, the name ARTS-1 is also used for a TNF-receptor-shedding aminopeptidase regulator, and
MART-1 is the gene name for a melanoma tumor antigen recognized by T cells. Therefore, despite the significant differences in the sequences
and functions of these splice variants, we propose that they be named SEPT4_v5 and SEPT4_v6.
e Note: the N-terminus of the known rat SEPT5 (MDSLAAPQ-) is unrelated to that of the human SEPT5. There are splice variants of both
human and rat SEPT5, but the 5 ends have not been unambiguously determined.
f A partial sequence of a possible longer variant (that begins RRGSGCAR) has been described.
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